Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)-Reference-Cited by-同舟云学术

Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)

Published:2020-02-05 Issue:4 Volume:30 Page:263-274
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Zhao Chunlong¹,Dong Hang¹,Xu Qifu¹,Zhang Yingjie¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Ji’nan, China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2020.1725470

Reference62 articles.

1. Chemical and structural biology of protein lysine deacetylases

2. The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat

3. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

4. Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histone deacetylases and their inhibitors in inflammatory diseases;Biomedicine & Pharmacotherapy;2024-10

2. Small molecule inhibitors targeting heat shock protein 90: An updated review;European Journal of Medicinal Chemistry;2024-09

3. Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation;Pharmaceuticals;2024-08-15

4. Sodium Butyrate (NaB) and Sodium Propionate (NaP) Reduce Cyclin A2 Expression, Inducing Cell Cycle Arrest and Proliferation Inhibition of Different Breast Cancer Subtypes, Leading to Apoptosis;Biomedicines;2024-08-06

5. Crucial Structural Understanding for Selective HDAC8 Inhibition: Common Pharmacophores, Molecular Docking, Molecular Dynamics, and Zinc Binder Analysis of selective HDAC8 inhibitors;Medicinal Chemistry;2024-07-19